Pharmaceutical companies can make better decisions with a new platform that analyzes partnerships and collaborations.
The pharmaceutical industry has shifted focus to partnerships, sharing resources and risks to speed up the development process. A new platform, the Partnership Tracker, helps analyze these partnerships for products and companies. This platform aims to assist pharmaceutical companies in making informed decisions.
Abstract
The pharmaceutical industry involves long and complicated processes for developing new products, changing rules from regulators, and more demands to create new treatments quickly and cheaply. In the last 15 years, the way companies do research, development, marketing, and distribution has changed a lot, with more focus on working together with other companies. These partnerships are important because they help share resources, risks, and speed up the process - which is very important in an industry where developing a product can take over ten years and cost billions of dollars. To help with this, the Partnership Tracker project has created a new platform that makes it easier to analyze these partnerships for both products and companies, helping pharmaceutical companies make better decisions.
References
- 1.Sharma, R. (2020). Health Care Collaboration: A Key to Innovation. Journal of Healthcare Management, 65(1), 12-25.
- 2.Berger, M. (2021). The Importance of Collaborations in Biotechnology and Pharmaceuticals. Biotechnology Advances, 49, 107745.
- 3.Baker, S., et al. (2019). How Artificial Intelligence is Transforming the Pharmaceutical Industry. Harvard Business Review.
- 4.PharmaCircle live data